Zylox-Tonbridge Medical Technology Co., Ltd. (FRA:818)

Market Cap	747.55M +9.3%
Revenue (ttm)	128.77M +35.1%
Net Income	29.76M +143.7%
EPS	0.09 +147.0%
Shares Out	n/a
PE Ratio	25.12
Forward PE	16.49
Dividend	0.04 (1.83%)
Ex-Dividend Date	May 27, 2026

Volume	n/a
Open	2.120
Previous Close	2.160
Day's Range	2.100 - 2.120
52-Week Range	1.960 - 2.980
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 17, 2026

About FRA:818

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally. It offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. The company’s peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as cove...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2012
• Employees: 925
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 818

Financial Performance

In 2025, FRA:818's revenue was 1.06 billion, an increase of 35.15% compared to the previous year's 782.48 million. Earnings were 244.37 million, an increase of 143.75%.

Financial numbers in CNY